Transduced p16(INK4a) peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G(1)

Citation
Dr. Gius et al., Transduced p16(INK4a) peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G(1), CANCER RES, 59(11), 1999, pp. 2577-2580
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
11
Year of publication
1999
Pages
2577 - 2580
Database
ISI
SICI code
0008-5472(19990601)59:11<2577:TPPIHO>2.0.ZU;2-H
Abstract
Progression of cells through the G(1) phase of the cell cycle requires cycl in D:Cdk4/6 and cyclin E:Cdk2 complexes; however, the duration and ordering of these complexes remain unclear. To address this, we synthesized a pepti dyl mimetic of the Cdk4/6 inhibitor, p16(INK4a) that contained an NH2-termi nal TAT protein transduction domain. Transduction of TAT-p16 wild-type pept ides into cells resulted in the loss of active, hypophosphorylated pRb and elicited an early G(1) cell cycle arrest, provided cyclin E:Cdk2 complexes mere inactive. We conclude that cyclin D:Cdk4/6 activity is required for ea rly G(1) phase cell cycle progression up to, but not beyond, activation of cyclin E:Cdk2 complexes at the restriction point and is thus nonredundant w ith cyclin E:Cdk2 in late G(1).